Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Pediatr Neurol. 2021 Mar 5;119:3–10. doi: 10.1016/j.pediatrneurol.2021.02.006

TABLE 4.

Demographic and SWS Characteristics Related to ASM Use in Patients With Seizures

Characteristic Using Levetiracetam Versus Not Using Using Oxcarbazepine Versus Not Using Using Phenobarbital Versus Not Using Off versus On ASMs Using Aspirin Versus Not Using Adults Off Versus On ASMs Hx of Brain Surgery, Off Versus On ASMs
Sex 0.713 0.531 0.389 0.555 0.217 0.022 0.236
Ethnicity 0.420 0.302 0.248 0.182 0.684 0.310 0.370
Race 0.181 0.010 0.127 0.180 0.790 1.000 1.000
B.I. laterality 0.440 0.753 0.003 0.126 0.163 0.571 1.000
Brain surgery 0.004 0.389 0.420 0.001 0.037 1.000
Glaucoma present 1.000 0.262 0.866 0.691 1.000 0.394 0.703
Uni versus bi glaucoma 0.068 0.146 0.023 0.300 0.105 0.130 1.000
PWB present 0.862 0.592 0.228 0.777 0.165 1.000 0.128
Uni versus bi PWB 0.597 1.000 0.281 1.000 0.509 0.020 1.000

Abbreviations:

ASM = Antiseizure medication

B.I. = Brain Involvement

Bi = Bilateral

Hx = History

PWB = Port-wine birthmark

SWS = Sturge-Weber syndrome

Uni = Unilateral

Bold face denotes a significant P value.

Fisher’s exact test.